Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study shows new test for ovarian cancer is 100% effective

20.07.2004


The journal Endocrine-Related Cancer today publishes work showing that scientists from the Clinical Proteomics Program of the US National Cancer Institute (NCI) have discovered a test that was 100% effective for detecting early ovarian cancer in their study.



The study describes the use of a high-resolution mass spectrometer to measure patterns of protein markers in a small sample of blood. The mass spectrometer measured slight differences in the weights between normal and cancerous proteins, enabling the researchers to identify the cells that would lead to cancer. The results of the trial revealed 100 percent sensitivity and 100 percent specificity for the detection of ovarian cancer, including the correct classification of all stage I ovarian cancer cases (where the cancer is still confined to the ovaries).

There are about 6,800 new cases of ovarian cancer each year in the UK, making it the fourth most common cancer among British women*.


Dr Tim Veenstra of the NCI Biomedical Proteomics Program and lead author of the study stated “This system is the latest generation of the technology we first described in Lancet in 2002. In this new study we used a larger set of new clinical samples (250 samples), and we showed that a higher resolution instrument could achieve higher sensitivity and specificity compared to the lower resolution instrument used previously.”

Dr Emanuel Petricoin of the FDA stated “This is the first step of the rigorous validation necessary as we attempt to speed this technology to broad public benefit.” Dr Lance Liotta of the NCI stated, “We incorporated new quality control methods into this latest study, and achieved 100% sensitivity and specificity in blinded testing and validation sets. We are focusing on ovarian cancer as a high priority because early diagnosis could have a major impact on treatment outcome.”

Dr Veenstra added “At present, this is a system in development, so it’s not yet suitable for a routine screening programme. However this method promises a real step forward in detecting ovarian cancer at an early stage. We hope that within a few years we will be able to develop a system which will enter routine diagnostic use.”

Jane Shepley | alfa
Further information:
http://www.endocrinology.org

More articles from Life Sciences:

nachricht Dead cells disrupt how immune cells respond to wounds and patrol for infection
21.05.2019 | University of Sheffield

nachricht New study shows: Tropical corals reflect ocean acidification
21.05.2019 | Leibniz-Zentrum für Marine Tropenforschung (ZMT)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Self-repairing batteries

UTokyo engineers develop a way to create high-capacity long-life batteries

Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...

Im Focus: Quantum Cloud Computing with Self-Check

With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.

Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...

Im Focus: Accelerating quantum technologies with materials processing at the atomic scale

'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.

However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...

Im Focus: A step towards probabilistic computing

Working group led by physicist Professor Ulrich Nowak at the University of Konstanz, in collaboration with a team of physicists from Johannes Gutenberg University Mainz, demonstrates how skyrmions can be used for the computer concepts of the future

When it comes to performing a calculation destined to arrive at an exact result, humans are hopelessly inferior to the computer. In other areas, humans are...

Im Focus: Recording embryonic development

Scientists develop a molecular recording tool that enables in vivo lineage tracing of embryonic cells

The beginning of new life starts with a fascinating process: A single cell gives rise to progenitor cells that eventually differentiate into the three germ...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

SEMANTiCS 2019 brings together industry leaders and data scientists in Karlsruhe

29.04.2019 | Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

 
Latest News

Synthesis of helical ladder polymers

21.05.2019 | Materials Sciences

Ultra-thin superlattices from gold nanoparticles for nanophotonics

21.05.2019 | Materials Sciences

Chaperones keep the tumor suppressor protein p53 in check: How molecular escorts help prevent cancer

21.05.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>